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CIITA is the master regulator of class II major histocompatibility complex gene expression. We present
evidence that CIITA can self-associate via two domains: the C terminus (amino acids 700 to 1130) and the
GTP-binding domain (amino acids 336 to 702). Heterotypic and homotypic interactions are observed between
these two regions. Deletions within the GTP-binding domain that reduce GTP-binding and transactivation
function also reduce self-association. In addition, two leucine residues in the C-terminal leucine-rich repeat
region are critical for self-association as well as function. This study reveals for the first time a complex pattern
of CIITA self-association. These interactions are discussed with regard to the apoptosis signaling proteins,
Apaf-1 and Nod1, which share domain arrangements similar to those of CIITA.
Major histocompatibility complex (MHC) class II proteins
play a critical role in the initiation of immune responses by
presenting peptides from exogenous antigens to T-helper lym-
phocytes (11, 48). The expression of MHC class II genes is
restricted to specific cell types with constitutive expression in B
lymphocytes and dendritic cells. In addition, a variety of cell
types can be induced to express MHC class II by the proin-
flammatory cytokine gamma interferon.
The cis-acting elements and the DNA-binding transcription
factors that regulate MHC class II expression have been ex-
tensively characterized (6, 20). MHC class II gene promoters
all contain a well-conserved tripartite arrangement of S, X, and
Y sequence elements. The X box can be subdivided into X1
and X2 elements. The class II X1 box binding factor, RFX, has
been shown to be defective in a rare immune deficiency, bare
lymphocyte syndrome (BLS) (38, 50). Genetic complementa-
tion of the defects in these cells resulted in the identification of
the components for this DNA-binding transcription factor.
RFX is composed of three subunits: RFX5 (56), RFXAP (17),
and RFX-B (RFXANK) (43, 46). The X2 element binding
protein has recently been identified as CREB (45). While the
X box is uniquely present in MHC class II promoters, the Y
box is a CCAAT box that is present in a large number of
eukaryotic promoters (9, 41). This site is bound by yet another
heterotrimeric factor, NF-Y (40, 52).
Although the transcription factors that bind the class II
boxes are required for the expression of MHC class II genes,
their presence alone is not sufficient for transcriptional activa-
tion. A major breakthrough in understanding MHC class II
gene expression was provided by complementation studies us-
ing the mutant cell line, RJ2.25 (1, 57). The initial isolation of
the CIITA cDNA revealed a large protein with an open read-
ing frame encoding 1,130 amino acids (57). CIITA is sufficient
for induction of MHC class II gene expression when intro-
duced into cells (10, 14, 58). In certain cases it also has been
implicated in the upregulation of MHC class I transcription
(21, 42). The N terminus of CIITA contains an acidic domain
that can activate transcription when fused to the DNA-binding
domain of GAL4 (51, 64). However, CIITA has not been
demonstrated to possess any DNA-binding activity. To date, a
number of proteins have been described that interact with the
amino-terminal sequences of CIITA, including CBP, PCAF,
TFIID components, and P-TEFb (18, 19, 31, 36, 39, 54). More
recently, it has been shown that CIITA can directly bind to
DNA-binding proteins which recognize the MHC class II pro-
moter, including NF-YB, NF-YC, RFX-5, RFX-B (RFX-
ANK), and CREB (16, 22, 65). CIITA interactions are also
observed when these factors are organized into an MHC class
II promoter-bound enhanceosome complex (44). These inter-
actions support the model of CIITA functioning as a coactiva-
tor for MHC class II promoters.
CIITA also has some features unique for a transcriptional
activator (24). CIITA was recognized to have sequence simi-
larities to GTP-binding proteins (13), and subsequently CIITA
has been demonstrated to be a GTP-binding protein (23).
Mutation of the consensus GTP-binding motifs results in loss
of function and the accumulation of CIITA in the cytoplasm. A
variety of mutations in the C terminus of CIITA have been
described in several BLS patient cell lines, underscoring the
functional importance of this region (5, 49, 57). In one of these
cell lines, defective splicing results in deletion of an exon con-
taining a nuclear import sequence. This results in loss of trans-
activation and the cytoplasmic localization of CIITA (15).
In this study, we describe the self-association of CIITA. This
self-association is complex and involves at least two types of
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interactions mediated by the peptide sequences within the
GTP-binding domain of CIITA and the C terminus (amino
acids 700 to 1130), which includes the leucine-rich repeats
(LRR). The former is able to interact both with itself and with
the LRR contained in the C terminus, while the C terminus
also self-associates. Thus, multiple intermolecular, as well as
intramolecular, interactions may occur. We discuss the simi-
larities of this interaction with those displayed by Apaf-1 and
Nod1, both mediators of apoptosis. CIITA serves a drastically
different function as a transcriptional activator and represents
the first of its kind to self-associate via a similar mechanism.
The significance is discussed in the context of an emerging
family of nucleotide-binding domain and LRR domain con-
taining mammalian proteins that display similarity to CIITA.
MATERIALS AND METHODS
Cell lines and culture. COS-7 and HeLa cells were cultured in Dulbecco
modified eagle medium (high glucose) supplemented with 10% fetal bovine
serum and 5 mM L-glutamine.
Plasmids. The FLAG-CIITA expression vector has been described previously
(13). The myc-CIITA pcDNA3 expression vector and the C-terminal deletion
mutants FLAG-C2 1-335, 1-612, 1-793, and 336-1130 have recently been de-
scribed (65). The C-terminal deletion mutants FLAG-C2 1-401, 1-650, 1-702,
1-751, and 1-852 were generated using the QuickChange mutagenesis protocol
with Pfu Turbo from Stratagene (La Jolla, Calif.). The sense primers used for
mutagenesis were as follows: 1-401, 59-GGCTGAGGTGCTGTaGGCTGCCAA
GGAGC-39; 1-650, 59-GGCCGTGCAGCCCTCtAgAGCCCCCCCGGGGCC-
39; 1-702, 59-CCACCGCGGGCCGCAtAGTCCGAGCTGGCC-39; 1-751, 59-
CCTATGACAACTGGCTGtAGGGCGTGCCACGC-39; and 1-852, 59-GGGC
AAGGCCTTGtAGGCGGCGGGCCAAGACTTCTCC-39 (lowercase letters
represent mutated bases). The myc-C2 1-852, 1-793, 1-751, and 1-702 expression
plasmids were generated by ligating the 1.6-kb SacII/XhoI fragment containing
the stop codons into SacII/XhoI-digested myc-CIITA. The myc-C2 1-612 and
1-650 deletion mutants were prepared by using QuickChange mutagenesis to
introduce stop codons at positions 613 and 651, respectively.
The expression vector pcDNA3 HisC was obtained from Invitrogen (Carlsbad,
Calif.). This expression vector allows for the amino-terminal tagging of CIITA
with a hexahistidine tag and an Xpress epitope tag (Xpress-CIITA). Full-length
Xpress-CIITA was created by ligating the EcoRI FLAG-CIITA insert into
EcoRI-digested pcDNA3 HisC. Xpress-tagged 336-1130 was generated by intro-
duction of a BglII site into CIITA using the QuickChange mutagenesis protocol.
The BglII/EcoRI fragment was inserted into BamHI/EcoRI-digested pcDNA3
HisC (Invitrogen). Xpress-CIITA 336-702 was generated after ligating the SacII/
XbaI fragment of FLAG-C2 1-702 into SacII/XbaI-digested Xpress-CIITA 336-
885.
The internal deletion construct FLAG-C2 1-335:700-1130 was generated by
creating an in-frame SacII site at codons 335 and 336 of CIITA using Quick-
Change mutagenesis. SacII digestion removed the sequences between this de-
signed site and the existing SacII site present at codons 699 and 700 of CIITA.
Religation allowed the removal of sequences encoding amino acids 336 to 699.
FLAG-C2 700-1130 was created by inserting the SacII/XhoI fragment into a
modified pcDNA3 vector that allowed for in-frame fusion of peptide sequence to
a FLAG tag using a SacII site. SacII sites were also engineered into CIITA at
codons 885 and 886 and codons 938 and 939 using QuickChange mutagenesis to
create FLAG-C2 886-1130 and 939-1130 expression plasmids.
Mutations in the LRR domain were generated using the QuickChange mu-







CGTGTGCTTCCG-39; and, L1092A, 59-GCCGGGGCCCAGCAGgcCGCTGC
CAGCCTTCGG-39. The mutations were transferred into the BamHI/XhoI-
digested FLAG-C2 939-1130 expression vector by inserting the BamHI/XhoI
insert from the full-length constructs described above. To generate full-length
myc-tagged leucine-to-proline mutants of CIITA, SacII/XhoI inserts encoding
the site-specific mutations were transferred into SacII/XhoI-digested myc-CIITA
expression vector. To generate myc-tagged GTP1D, GTP2D, and GTP3D mu-
tants, NotI inserts encoding the mutation were ligated to NotI-digested and
dephosphorylated myc-CIITA. All constructs were verified by sequence analysis.
The pcDNA3 expression vector for FLAG-tagged murine p38 was provided by
Lee Madrid (laboratory of Albert Baldwin).
Immunoprecipitation and Western blotting. COS-7 cells were split 2 3 105
cells per well in six-well plates the evening before transfection. Cells were trans-
fected with 500 ng of each expression vector using Fugene 6 (Roche Molecular
Biochemicals, Indianapolis, Ind.) according to the standard protocol. At 30 h
after transfection, the cells were washed twice with cold phosphate-buffered
saline and lysed on the plate with 700 ml of radioimmunoprecipitation assay
(RIPA) buffer (10 mM Tris, pH 7.4; 200 mM NaCl; 1% Nonidet P-40 [NP-40];
0.5% sodium deoxycholate, 0.1% sodium dodecyl sulfate [SDS], 5 mM EDTA, 1
mM dithiothreitol) supplemented with protease inhibitors (Complete EDTA-
free; Roche). After centrifugation, 600 ml of the supernatant was transferred to
a separate Eppendorf tube and incubated with 1 mg of anti-myc 9E10 or anti-
Xpress antibody (Invitrogen) for 1 h at 4°C. Then, 5 ml of prewashed goat
anti-mouse M-450 Dynabeads (Dynal, Oslo, Norway) was added, and the com-
plexes were incubated with rotation for 3 h at 4°C. The complexes were washed
three times for 10 min each using 500 ml of the lysis buffer. Immunoprecipitated
protein was denatured using Laemmli buffer, and the samples were subjected to
SDS-polyacrylamide gel electrophoresis. The gels were transferred to nitrocel-
lulose for 1 h at 100 V. For experiments using the FLAG-C2 939-1130
expression vectors polyvinylidene difluoride (Immobilon P; Millipore, Bedford,
Mass.) was used, and SDS was omitted from the transfer buffer. The membranes
were blocked using 5% milk in Tris-buffered saline–Tween (10 mM Tris, pH 8.0;
150 mM NaCl; 0.05% Tween 20) for 1 h. For detection of FLAG-tagged pro-
teins, anti-FLAG M5 was used (Sigma, St. Louis, Mo.). For detection of myc-
and Xpress-tagged proteins in immunoprecipitated complexes, one-quarter of
the denatured protein was run on a separate gel and blotted independently of the
FLAG-tagged proteins. For detection of myc-tagged proteins, anti-myc 9E10 was
used. Secondary detection of the bound primary antibody utilized horseradish
peroxidase (HRP)-conjugated goat anti-mouse heavy- and light-chain (k)-spe-
cific antibodies from Southern Biotechnology (Birmingham, Ala.). HRP detec-
tion was performed using Supersignal West Pico Chemiluminescent substrate
(Pierce, Rockford, Ill.).
In vitro translation. Plasmids were transcribed and translated in vitro using
the TNT T7 Kit (Promega, Madison, Wis.). For each reaction, 1 mg of each
indicated plasmid was incubated with 40 ml of the reticulocyte lysate in the
presence of 2 ml of [35S]methionine for 90 min at 30°C. Then, 1 ml of the reaction
was withheld for detection of the input protein, and the remainder of the
reaction was split equally into 500 ml of NP-40 buffer (10 mM Tris, pH 7.4; 140
mM KCl; 20 mM NaCl; 5 mM EDTA; 1% NP-40) and into the same volume of
COS-7 cell lysate prepared using the same buffer. Immunoprecipitations were
performed using 1.5 mg of the anti-Xpress antibody according to the procedure
described above.
Luciferase assays. HeLa cells were split 2 3 105 cells per well in six-well plates
the evening before transfection. A total of 1 mg of each CIITA expression vector
was cotransfected with 1 mg of pGL2-DRA 300 (23). Cells were harvested using
reporter lysis buffer (Promega) 18 h after transfection. Luciferase activity was
normalized to lysate protein content using the Bio-Rad protein assay.
RESULTS
CIITA self-association can be detected in cells but not using
in vitro-translated mixtures. Previous analysis of CIITA indi-
cated that certain mutants had the ability to antagonize wild-
type CIITA in a dominant-negative fashion (12, 13). In order
to test the hypothesis that this inhibition could be mediated
through dimerization of CIITA, COS-7 cells were cotrans-
fected with expression vectors for CIITA tagged with both myc
and FLAG epitopes. Cell lysates were prepared using RIPA
buffer and immunoprecipitated with anti-myc antibody. West-
ern blots were performed to detect coimmunoprecipitation of
the FLAG-tagged CIITA protein. FLAG-CIITA coimmuno-
precipitated with myc-CIITA (Fig. 1A, lane 3). Immunopre-
cipitation with an isotype control, immunoglobulin G1 (IgG1),
did not pull down either myc-CIITA or FLAG-CIITA (Fig.
1A, lane 2). As a negative control, an unrelated protein, p38,
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also failed to coimmunoprecipitate with CIITA (Fig. 1A, lane
4). In addition, we have previously shown that CIITA does not
interact with NF-YA (65). Similar results were obtained when
using a lysis buffer containing NP-40 as the sole detergent (data
not shown). Comparing the signals from total input and im-
munoprecipitated fractions, it can be estimated that less than
5% of the input FLAG-CIITA coimmunoprecipitated. Since
interactions between CIITA molecules with like tags should
also occur, less than 15% of the total cellular CIITA would be
self-associating in this system.
FIG. 1. Detection of CIITA self-association using a cellular expression system. (A) FLAG-tagged CIITA coimmunoprecipitates with myc-
tagged CIITA in a COS-7 cell expression system. COS-7 cells were cotransfected with pcDNA3 expression vectors encoding the full-length CIITA
cDNA (clone 8, amino acids 1 to 1130) with N-terminal FLAG or myc epitope tags. The middle panel shows the results for immunoprecipitation
(IP) with anti-myc 9E10 or anti-Xpress as an IgG1 negative control, followed by immunoblotting (IB) with anti-FLAG M5 antibody. The
stress-activated protein kinase, p38, served as an irrelevant FLAG-tagged protein control. Expression of FLAG-tagged proteins was verified by
performing an anti-FLAG M5 Western blot using 2% of the RIPA lysate (top panel). Expression and immunoprecipitation of the myc-CIITA was
confirmed in the bottom panel. Detection of the light chain from the monoclonal antibodies is designated with an “LC.” (B) CIITA self-associates
in HeLa cells. Expression and detection of CIITA self-association is performed using the same procedure as in panel A, with immunoprecipitation
using anti-FLAG M2-conjugated agarose beads. Expression levels of FLAG-CIITA for the COS-7 and HeLa experiments are shown in the bottom
panel. (C) CIITA fails to self-associate when using an in vitro translation system. FLAG-tagged CIITA was cotranslated with an Xpress-tagged
CIITA. [35S]methionine-labeled in vitro-translated proteins were incubated with anti-Xpress antibody in the absence or presence of COS-7 cell
lysate and immunoprecipitated with goat anti-mouse Dynabeads. No immunoprecipitation was detected for FLAG-CIITA (lanes 2 and 29) or a
C-terminal deletion mutant FLAG-C2 1-612 (lanes 3 and 39), which was shown to coimmunoprecipitate using the COS-7 expression system (see
Fig. 3B). The FLAG-tagged deletion mutant was included because of its obvious size difference from full-length Xpress-CIITA, since full-length
FLAG-CIITA and Xpress-CIITA were difficult to distinguish.
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To rule out the possibility that the expression of large quan-
tities of CIITA might lead to nonspecific association, we re-
peated the experiment in HeLa cells. These cells do not harbor
the simian virus 40 large-T antigen; thus, they do not amplify
the pcDNA3 expression vector. In this experiment, CIITA was
immunoprecipitated with anti-FLAG antibody. Myc-tagged
CIITA coimmunoprecipitated in HeLa cells (Fig. 1B, lane 2).
In three experiments, the level of CIITA expression in HeLa
was approximately 1/10 that of COS-7. The transfection effi-
ciency was monitored using green fluorescent protein cotrans-
fection and was equivalent for both cell types (52% for HeLa,
60% for COS-7).
In contrast to the results obtained from the cell expression
systems, in vitro-translated Xpress-tagged CIITA failed to co-
precipitate FLAG-tagged CIITA. Full-length FLAG-CIITA
was cotranslated with Xpress-tagged CIITA in the presence of
[35S]methionine. The former has a slightly faster migration
pattern than the latter (compare the top bands in Fig. 1C, lanes
1 and 3 which, respectively, represent FLAG-CIITA and
Xpress-CIITA). When an anti-Xpress antibody was used for
the immunoprecipitation, the slightly smaller FLAG-CIITA
failed to coprecipitate. To better distinguish the two differen-
tially tagged molecules, we used a FLAG-CIITA molecule that
is significantly smaller and easily distinguishable from the full-
length Xpress-CIITA (Fig. 1C, lane 3 [FLAG-C2 1-612]) but
readily self-associates in vivo (see Fig. 3B). FLAG-C2 1-612
also did not coprecipitate with Xpress-CIITA. In a previous
study, we showed that similarly prepared CIITA coprecipitates
NF-YB, NF-YC, and RFX5 (65); thus, in an in vitro translation
extract, CIITA, interacts with other proteins but not with itself.
The failure to interact could not be rescued by the presence of
COS-7 cell lysate (lanes 29 and 39), suggesting that the simple
presence of a bridging or adapter protein was not the factor
resulting in the lack of precipitation. This suggests at least two
possibilities: (i) that CIITA undergoes a modification inside
cells that promotes self-association and/or (ii) that an adapter
molecule, if it exists, has to associate with CIITA in cells. The
detection of CIITA self-association exclusively in intact cells
prompted us to perform all of the following studies in trans-
fected cells.
Mapping the self-association domains of CIITA. In order to
characterize the domains involved in the self-association
events of CIITA, we proceeded with the COS-7 cell expression
system. For an initial mapping of peptide sequences required
for the observed self-association, a series of FLAG-tagged
N-terminal deletion mutants were employed. These mutants
were coexpressed with myc-tagged full-length CIITA to exam-
ine regions required for association. Figure 2A depicts the
sequences that are removed in these deletion mutants. Surpris-
ingly, the FLAG-C2 mutants 336-1130, 700-1130, 886-1130,
and 939-1130 all interacted with full-length CIITA (Fig. 2B,
see lanes 3 through 6). These results provide evidence that the
last 192 amino acids of CIITA contain sequences involved in
the self-association. This region of CIITA contains six poten-
tial LRR, and the data are consistent with the global hypoth-
esis that these repeat structures are frequently involved in
mediating protein interactions (34).
We applied a similar strategy using C-terminal FLAG-
tagged deletion mutants to further delineate the self-associa-
tion sequences. These constructs are shown in Fig. 3A. Dele-
FIG. 2. CIITA amino acids 939 to 1130, which includes the LRR
region, interacts with full-length CIITA. (A) Graphical representation
of the N-terminal deletion mutants used to map sites required for the
CIITA self-association. The N terminus of CIITA contains the acidic
domain (30-130), and the proline (P)-, serine (S)-, and threonine
(T)-rich regions. Exon 8 encodes the CIITA peptide sequence from
amino acids 336 to 886, and this region is shaded in gray. GTP-binding
motifs are indicated at their respective positions by G1 (phosphate
binding, amino acids 420 to 427), G3 (Mg21 coordination, amino acids
461 to 464), and G4 (guanine specificity, amino acids 558 to 561). The
LRR are located at the extreme C terminus of CIITA (amino acids 957
to 1127). (B) Full-length myc-tagged CIITA was cotransfected into
COS-7 with a series of FLAG-tagged N-terminal deletion mutants. An
anti-FLAG M5 Western blot on 2% of the RIPA lysate validated
expression of the FLAG-tagged deletion constructs. The middle panel
shows an anti-FLAG M5 immunoblot after immunoprecipitation (IP)
with the anti-myc 9E10 antibody. Heavy chain from the monoclonal
anti-myc antibody was detected by the goat anti-mouse secondary
antibody and is noted by “HC.” The results were repeated in three
experiments using RIPA buffer.
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tions of CIITA sequence up to amino acid 612 retained the
ability to interact with the full-length myc-tagged CIITA (Fig.
3B). Further deletions beyond the phosphate-binding motif of
the GTP-binding domain (G1, amino acids 421 to 428) resulted
in two deletion mutants, 1-401 and 1-335, that did not associate
with full-length CIITA (Fig. 3B, lanes 3 and 4). An additional
deletion mutant, 1-421, was also never observed to bind to
full-length CIITA, although the expression level was consis-
tently low and hence the construct was not included in this
experiment (data not shown).
The initial interaction mapping with the N- and C-terminal
deletions indicates that the amino-terminal sequence of
CIITA, which includes the acidic domain, the proline-, serine-,
and threonine-rich regions, and the sequences up to the
phosphate-binding motif, are not sufficient for CIITA self-asso-
ciation. Additionally, these studies identified two domains in-
volved in self-association: residues 401 to 612, containing the
GTP-binding domain, and the C-terminal LRR.
Homotypic self-association between residues 336 and 702 of
CIITA. The data from the deletion mutant analysis suggest that
sequences contained in residues 1 to 612 are potentially in-
volved in self-association (Fig. 3), while the N-terminal dele-
tion mutant analysis suggests that the extreme C terminus
(residues 939 to 1130) contained sequences that are sufficient
for self-association (Fig. 2). Since both of these sets of mutants
were tested against full-length CIITA as the associative part-
ner, one explanation is that interactions among multiple do-
mains may occur. To resolve this paradox, the analysis of an-
other nucleotide-binding protein that self-associates provided
an interesting model upon which we began to address further
mapping of interaction sites. The apoptosis signaling protein,
Apaf-1, displays a complex set of interactions that include
multimerization of its nucleotide-binding domain (NBD) (55).
Similar events are also observed in the C. elegans Apaf-1 ho-
mologue, CED-4 (63). Since it was unclear from the prior
experiments how the different regions of CIITA were mediat-
ing the in vivo interaction, these regions of CIITA were iso-
lated and tested against each other.
In order to determine whether the GTP-binding domain
could interact with itself, two sets of experiments were per-
formed. First, the deletion mutants used in Fig. 3 were tagged
with the myc epitope and tested against identical FLAG-
tagged deletion mutants. Deletion mutants FLAG-C2 1-852,
1-793, 1-751, 1-702, 1-650, and 1-612 interacted with the cor-
responding myc-tagged constructs (Fig. 4A), indicating that
residues 1 to 612 were sufficient for self-interaction. The ex-
pression of the 1-612 construct was lower than the other con-
structs (Fig. 4A, top and bottom panels). This largely accounts
for the lower level of coprecipitated product.
To further determine if the GTP-binding domain could self-
associate, it was isolated from the N-terminal sequences (res-
idues 1 to 335) and tested against itself in a coimmunoprecipi-
tation assay. Residues 336 to 702 of CIITA were tagged with an
Xpress epitope and cotransfected with a FLAG-tagged 336-
702 expression vector. This region interacted with itself (Fig.
4B, lane 2) but not with the C-terminal deletion FLAG-C2
1-335 (Fig. 4B, lane 3), which has been shown to lie outside of
the self-associative domain (Fig. 2B and 3B). The Xpress-
tagged residues 336 to 702 did not interact with a negative
control protein, FLAG-tagged p38 (Fig. 4B, lane 4). Cotrans-
fection with the empty pcDNA3 vector also did not result in
coprecipitation of the FLAG-C2 336-702 protein, demonstrat-
ing the specificity of the anti-Xpress antibody (Fig. 4B, lane 1).
Similar findings have been noted in HeLa cells (data not
shown).
A second mode of CIITA self-association involves the C-
terminal sequences from residues 700 to 1130. An internal
deletion within CIITA was constructed deleting residues 336 to
FIG. 3. N-terminal amino acids 1 to 401 are expendable for inter-
action with full-length CIITA. (A) Graphical representation of the
C-terminal deletion mutants employed for interaction mapping in
panel B. The domain representation is the same as that used in Fig.
2A. (B) Full-length myc-tagged CIITA was cotransfected into COS-7
cells with a series of FLAG-tagged C-terminal deletion mutants. A
secondary antibody specific for mouse light chain (k) was used to avoid
detection of the heavy chain. Results for the FLAG-C2 1-335, 1-612,
and 1-793 deletion mutants have been repeated in excess of 10 times.
Similar results are seen when an NP-40 lysis buffer was used. The
results for all other deletion mutants have been repeated three times.
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699. This fuses the sequence from residues 700 to 1130 to the
N-terminal domain of CIITA. Residues 1 to 335 were included
since these allowed better detection of the C-terminal se-
quences and did not appear to be involved in any self-associ-
ation. FLAG- and myc-tagged versions of this construct were
cotransfected into cells. Figure 4C shows that these two copre-
cipitated with each other (Fig. 4C, lane 2), whereas there was
no interaction with residues 1 to 335 (Fig. 4C, lane 3). This
indicates that residues 700 to 1130 may also mediate homo-
typic self-association.
The LRR sequences in 939-1130 interact with residues 336
to 702. In addition to homotypic association of the Apaf-1
NBD, heterotypic domain association is observed between the
C-terminal WD-40 repeats and the NBD (27). This prompted
us to assay for an association between the GTP-binding do-
main and the LRR region of CIITA. FLAG-C2 939-1130 co-
precipitated with the Xpress-tagged 336-702 CIITA sequences,
indicating heterotypic association (Fig. 5B, lane 2). Therefore,
although CIITA contains LRR as opposed to WD-40 repeats,
the complex self-interactions that Apaf-1 displays are mirrored
in the interactions detected thus far with CIITA.
Interactions of mutant LRR with the GTP-binding domain
of CIITA. To explore the functional significance of the LRR in
CIITA, a series of mutations were generated using the crystal
structure of the LRR-containing protein, Rna1p as a model
(25). Leucines within the putative alpha-helical region of the
repeat were changed to proline and alanine at residues 1007,
1035, 1064, and 1092 of wild-type CIITA (Fig. 5A). Mutation
to proline would be predicted to disrupt the helical component
of the repeat, whereas the alanine substitutions should be
much less disruptive to the helical structure. When these mu-
tant LRR were tested for their ability to interact with the
GTP-binding domain of CIITA, the L1035P mutation consis-
tently showed significantly less interaction compared to the
wild type (Fig. 5B, compare lanes 2 and 4). Interaction with the
L1064P mutation was also consistently reduced (compare Fig.
5B, top panel, lanes 2 and 5, for the expression level, and the
second panel, same lanes for the degree of self-association).
Interactions with the two flanking LRR were studied using the
L1007P and L1092P mutations; these have little effect on self-
association. None of the alanine substitution mutants reduce
self-association. These results suggest that the two central
LRR are involved in association with the GTP-binding do-
main. The difference between the proline and alanine substi-
tutions at residues 1035 and 1064 suggests that the helical
sequences of these LRR are involved in association.
The effect of the leucine-to-proline mutations on self-asso-
ciation of full-length CIITA was also examined. In contrast to
the results seen when we tested the heterotypic interactions
between the isolated LRR and GTP-binding domains, none of
the leucine-to-proline mutants had a detectable effect on in-
termolecular self-association when tested within the context of
full-length CIITA (Fig. 5C, compare lanes 3 to 6 with lane 2).
This result was reproduced in HeLa cells (data not shown). A
FIG. 4. Self-association of CIITA is mediated in part by self-interactions between amino acids 336 to 702. (A) The FLAG-tagged C-terminal
stop mutants used in Fig. 3 were tested in COS-7 cells for association with a myc-tagged version of the same construct. Self-association of C2 1-612
and 1-793 has been observed using both NP-40 and RIPA buffers. (B) Isolated CIITA sequences from residues 336 to 702 can multimerize.
Expression vectors for amino acids 336 to 702 were designed with both FLAG and Xpress N-terminal epitope tags. Coexpression of the
differentially tagged constructs from amino acids 336 to 702 in COS-7 cells resulted in coimmunoprecipitation of the FLAG-tagged protein.
Coexpression of the FLAG-tagged 1-335 deletion mutant (lane 3) or the irrelevant protein control, FLAG-p38 (lane 4), did not result in
coimmunoprecipitation. These results have been verified in four experiments, including one using HeLa cells. (C) CIITA residues encoding amino
acids 700 to 1130 can associate with each other. A CIITA construct that deleted the region of residues 336 to 699 was made and designated as
1-335:700-1130. This removes most of the residues from 336 to 702 studied in Fig. 4B but retains the C terminus and the N-terminal region that
does not participate in any form of self-association.
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likely explanation for our inability to detect associative differ-
ences between these mutants is that the homotypic interaction
occurring between the GTP-binding domains of the two dif-
ferent CIITA molecules can still take place. This homotypic
association is likely sufficient to maintain the intermolecular
interaction.
To explore the significance of the LRR mutations on the
transactivating function of CIITA, these mutants were tested
for the capacity to activate an MHC class II promoter. In HeLa
cells, all LRR mutants severely abrogated transactivation, with
the exception of L1035A (Fig. 5D). Similar results were seen
when using the COS-7 and G3A cell lines (J. A. Harton, un-
published results). These results indicate that all the leucine
residues are critical for function, yet only two, L1035 and
L1064, show a demonstrable effect on the heterotypic associ-
ation shown in Fig. 5B. The results with L1035 are interesting
in that the L1035P mutation affects both association (Fig. 5B)
and function (Fig. 5D), whereas the L1035A mutation has no
effect in both assays. This correlation of association and func-
tion provides support, but not proof, for the contention that
association is linked to function. The difference between the
proline and alanine mutations of L1035 indicates that conser-
vation of helical structure is important. The role of the other
leucines in this heterotypic interaction is unclear at this point.
They may have a role in self-association that our approach fails
to detect, or they may be critical to other mechanisms not
revealed in this study.
Mutations in the GTP-binding domain decrease self-associ-
ation. Given the ability of the isolated GTP-binding domain to
self-associate (Fig. 4B), we tested whether mutating crucial
residues in the GTP-binding domain of full-length CIITA af-
fects intermolecular association. Previously, we have identified
sequences corresponding to the G1, G3, and G4 GTP-binding
motifs in CIITA (13). CIITA constructs bearing mutations in
each of these three motifs are named GTP1D, GTP2D, and
GTP3D, respectively (also see the Fig. 6, legend). These mu-
tants display reduced transactivation function and GTP-bind-
ing capacity (23). To determine if these mutants display re-
duced self-association, we initially cotransfected wild-type
CIITA together with each of these GTPD mutants. Although
in selected experiments a small decrease in self-association
was observed, these results were not reproducible (data not
FIG. 5. Mutation of leucines in the LRR and effects on self-association and transactivation function. (A) Targeted mutagenesis of the predicted
alpha- helix within individual LRR. The consensus sequence for the LRR is shown with alignment of the CIITA motifs shown below. The location
of the putative beta-sheet and alpha-helix is indicated under the consensus. The arrowhead indicates the leucine position targeted in the
mutagenesis strategy. (B) Mutation of leucine-1035 to proline and, to a lesser extent, leucine-1064 to proline decreases the association of the
C-terminal residues from 939 to 1130 with amino acids 336 to 702 of CIITA. FLAG-tagged expression vectors encoding the wild-type amino acid
sequence from 939 to 1130 of CIITA or mutant proteins with either leucine-to-proline or leucine-to-alanine substitutions in individual LRR were
coexpressed with the Xpress-C2 336-702 expression vector in COS-7 cells. The leucine mutations did not affect the expression of the 939-1130
proteins since expression was detected in each lane (top panel). The proline mutants were tested seven times, and alanine mutants were tested four
times. (C) Full-length LRR leucine-to-proline mutations do not interfere with CIITA self-association. LRR mutations were produced in the
context of full-length FLAG- and myc-CIITA and assayed for their capacity to self-associate using the conditions described in Fig. 1. (D) Effect
of LRR mutations on CIITA transactivation function. Full-length leucine-to-proline and leucine-to-alanine mutants were tested for their ability
to activate a DRA promoter luciferase reporter in HeLa cells. Luciferase activity is reported as percent activation relative to wild-type CIITA.
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shown). In contrast, when the myc- and FLAG-tagged CIITA
used in the coprecipitation assay both bear mutations in the
GTP-binding region, the effect on association was reproduc-
ible. GTP1D, GTP2D, and GTP3D mutants were cotransfected
in COS-7 cells. Most noteworthy, the GTP2D and GTP3D
mutants displayed reduced self-association (Fig. 6, lanes 4 and
5). The self-association observed between GTP1D mutant mol-
ecules was similar to that for wild-type CIITA (Fig. 6, lane 3).
Interestingly, the reduction observed for self-association par-
allels the reduction in transactivation potential of these mu-
tants (see the percent relative transactivation values at the
bottom of the figure) that we have previously described (13,
23). This strongly suggests that the GTP-binding domain is
important in self-association and further shows a correlation
between self-association and transactivating function.
DISCUSSION
Transcriptional activation involves highly specific interac-
tions among different components of the basal transcription
complex, site-specific DNA-binding proteins, coactivators, and
chromatin modifiers. Dimerization or multimerization pro-
vides an extra layer of regulation and complexity that can allow
for multiple signaling outcomes (32). In this study, we provide
evidence for a complex set of molecular interactions displayed
by the transcriptional coactivator, CIITA. These interactions
involve the region comprising residues 336 to 702 and the C
terminus of CIITA. The former encompasses the GTP-binding
domain and displays the capability for interactions both with
itself and with the C-terminal LRR. The data demonstrate a
complex pattern of association between distinct domains of
CIITA and imply that CIITA occurs as a dimer if not a mul-
timer. Our findings allow for the existence of several binding
configurations (Fig. 7A). The simplest of these is a “hairpin”
like monomer (Fig. 7A, diagram I), which would result from
intramolecular association of the GTP-binding domain with
FIG. 6. Mutations within the GTP-binding domain reduce CIITA
self-association Expression vectors encoding FLAG- and myc-tagged
versions of identical GTP-binding domain mutants were cotransfected
into COS-7 cells and tested for association. The consensus GTP-bind-
ing motifs are depicted in Fig. 2. GTP1D is a three-amino-acid deletion
in the G1 box (phosphate binding, D419–421). GTP2D is a four-amino-
acid deletion in the G3 box (Mg21 coordination, D461–464), and
GTP3D is a four-amino-acid deletion in the G4 box (guanine specific-
ity, D558–561). Previously published percent relative transactivation
data (13) as measured by a chloramphenicol acetyltransferase assay of
each of the mutants are listed below the line at the bottom of the panel.
FIG. 7. Model for self-association and similarity with other mam-
malian NBD-LRR proteins. (A) Graphical representation of the in-
teractions described in this study. Conformation I would likely alter-
nate with one of the other forms involving homotypic domain
interactions (e.g., II or III). Conformation II is a dimeric configuration
with homotypic domain interactions. This conformation would also
likely alternate with another (e.g., I, III, or IV). Conformation III is a
dimeric configuration with homotypic domain interaction (for amino
acids 336 to 702) and heterotypic domain interaction (amino acids 336
to 702 with LRR). Multiple copies of this dimeric unit (4-mer, 6-mer,
etc.) would allow for all observed interactions to occur simultaneously,
obviating the need for additional (or transitional) states. Conformation
IV is a dimeric configuration with heterotypic domain interactions.
Again, alternating this configuration with other configurations (e.g., II
or III) would be likely. (B) Schematic representation of recently de-
scribed mammalian proteins with similarity to CIITA. Each protein
contains a characterized or putative NBD and a series of C-terminal
LRR sequences of varying number. NBD-LRR proteins are also com-
mon among plant disease resistance genes, as typified by RPM1. The
scale shown indicates increments of 100 amino acids.
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the LRR. However, because our mapping experiments assay
only for intermolecular interaction of two differentially tagged
CIITA proteins, we can only infer that the intramolecular
interaction may take place: The other hypothetical configura-
tions all involve a form of intermolecular interaction (Fig. 7A,
diagrams II to IV).
The initial motivation for these studies was to investigate the
trans-dominant-negative function of CIITA mutants (12). One
potential mechanism that could explain the results is that dom-
inant-negative mutants could interact directly with wild-type
CIITA and block transactivation. Such self-association is
shown in this report. In light of the present data, it is possible
that the lack of either domain alters the proper balance of
self-association to result in the suppression of CIITA function.
It is also noteworthy that both the LRR and GTP-binding
domains have a role in nuclear translocation (15, 22, 23). It is
possible that mutations in these regions cause the protein to
assume different configurations, or different associative prop-
erties, leading to an effect on import function.
One important observation that arises from these studies is
the similarity of these interactions with those that have been
described for two other proteins that self-associate, i.e., Apaf-1
and Nod1 (28, 55). Apaf-1 initiates an apoptotic cascade in the
presence of cytochrome c and dATP (37). It contains an N-
terminal caspase recruitment domain (CARD), an NBD that
binds dATP, and C-terminal WD-40 repeats. The NBD of
Apaf-1 self-associates (55, 63), and the resultant oligomeriza-
tion is thought to induce the proximity of procaspase-9 mole-
cules, resulting in cleavage and activation. The C-terminal
WD-40 repeats of Apaf-1 interact with the NBD and regulate
the activity of Apaf-1 (2, 27, 55). CIITA demonstrates a similar
complex pattern of association, although it is unclear what
regulates the self-association of CIITA. Based on our data, it is
likely that the binding of GTP may represent such a regulatory
step. This is supported by the finding that reductions in self-
association observed with GTP-binding domain mutants cor-
relates directly with reductions in their transactivation poten-
tial. One caveat is that the disruption of the phosphate-binding
motif, G1, did not significantly influence the ability of CIITA
to self-associate, while this same mutation is known to de-
crease GTP-binding and transactivation function (23). Thus,
we also have to entertain the most conservative interpretation
that it is the integrity of the GTP-binding domain that is im-
portant for self-association and not the binding of GTP.
The second domain of CIITA that is involved in self-asso-
ciation lies in the C-terminal end, which contains a series of
LRR (8). Comparison of the LRR from diverse sources yields
the consensus sequence LXXLXLXX(N/C)XL(X)7L(X)3L, al-
though some variation from this consensus can be tolerated as
seen in the structure of Rna1p (25). Allowing for such varia-
tion, CIITA contains six potential repeats. LRR adopt a horse-
shoe-like structure composed of alternating beta-sheets and
alpha-helices with the beta-sheets lining the interior face and
the helices facing outward (33, 34). This motif can be found in
a variety of proteins and is thought to be involved in mediating
protein-protein interactions (8, 35). This global hypothesis is
supported by our results, which show interaction of the LRR
with the GTP-binding domain of CIITA.
The results in Fig. 5 indicate that only one of the LRR
mutations, L1035P, significantly disrupts binding to the GTP-
binding domain, while the L1064P mutation has a lesser effect.
The mutation of 1035 is most interesting because, while a
proline substitution caused the loss of transactivation function
and self-associative properties, an alanine substitution at this
site affected neither. This suggests that the helical structure of
these repeats, which is most affected by a proline substitution,
is actually more significant than an invariant leucine at that
site. Aside from these two mutations, mutations of the other
LRR motifs produced little effect on self-association, but most
caused a dramatic reduction of transactivation activity. The
basis for the lack of correlation between self-association and
transactivation function may be complicated by other molecu-
lar events that require an intact LRR domain. For example,
two mutants that self-associate but lack transactivation func-
tion, L1007P and L1092P, are exclusively found in the cyto-
plasm (J. A. Harton et al., unpublished data). Therefore, fail-
ure to localize to the nucleus can explain the lack of function
observed for these mutants. It is also possible that sequences in
addition to the LRR are important for self-association. Along
this vein, we have noted that while residues 700 to 1130 exhibit
strong homotypic association (Fig. 4C), homotypic associations
between residues 939 and 1130 are very weak (data not shown).
Finally, we have to consider the possibility that the LRR do-
main is not only involved in self-association but may also in-
teract with other proteins. Consistent with this hypothesis, the
association of CIITA with a 33-kDa protein has been shown to
be sensitive to LRR mutagenesis (22).
One crucial question that arises from this study is: why is it
necessary for CIITA to self-associate? The answer may lie in
recent data which show that CIITA serves as a scaffold for the
transcription factors involved in the regulation of MHC class II
genes (65). Multimerization of CIITA may enhance the asso-
ciation of these factors in vivo either with each other or with
the DRA promoter. This is similar to the induced proximity
models discussed for Apaf-1 and more recently for Nod1 and
Nod2 (29, 47, 62, 63). In contrast to the apoptosis signaling
proteins mentioned above, CIITA does not have a caspase
recruitment domain at the N terminus. Instead, the N terminus
of CIITA contains a transcriptional activation domain that
binds to a number of transcription factors (18, 19, 31, 36, 39).
Several factors with enzymatic activity bind in this region, in-
cluding the acetyltransferase activities of CBP (also called
p300) and PCAF (19, 36, 53, 54) and the RNA polymerase II
CTD phosphorylation activity of P-TEFb (31). Therefore, it is
possible that CIITA could function as a chaperone to induce
the proximity of these enzymatic activities at MHC class II
promoters.
Although CIITA and Apaf-1 do not display significant pri-
mary sequence homology, CIITA has been shown to be similar
in sequence to the other apoptotis signaling proteins, Nod1
(also known as CARD4) (4, 28) and Nod2 (47). Sequence
similarity with CIITA is strongest in the nucleotide-binding
domain and in the C-terminal LRR region. Using a BLAST
search of the GenBank database, we have found several other
proteins that display similarity to CIITA. These proteins share
similarity within their NBDs and are large proteins (typically
.1,000 amino acids in length) with LRR at their C termini
(Fig. 7B). DEFCAP contains an N-terminal pyrin domain and
a C-terminal CARD domain and appears to be yet another
NBD-LRR protein capable of signaling apoptosis (26). MA-
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TER is an ooplasm-specific maternal effect gene required for
embryonic development beyond the two-cell stage (59– 61),
and its mode of action is ill defined. Finally, some plant disease
resistance proteins, such as RPM1, share the NBD-LRR do-
main arrangement (3, 7, 8). Nod1 and Nod2 have recently been
shown to be involved in responses to bacterial products, most
notably lipopolysaccharide (30). A thought-provoking possibil-
ity in comparing CIITA, Nod1 and -2, and RPM1 is that plants
and animals may have adopted a similar molecular strategy to
fend off infections.
In summary, this study provides evidence that CIITA self-
associates and that this interaction involves the GTP-binding
domain and the C terminus, which includes the LRR. The
mode of self-association is reminiscent of other NBD-LRR
proteins, such as Nod1 and Apaf-1. CIITA is the first example
of a transcriptional coactivator that belongs to this group of
proteins. It is likely that the mechanisms that mediate self-
association among these distinct proteins are similar; however,
distinct biological functions are activated depending on the
“effector” domain that lies at the N termini. In the case of
CIITA, the N terminus contains a classical activation domain,
and thus gene transcription is activated. This study has broad
implications in the understanding of this emerging family of
proteins. Additionally, these findings have specific implications
regarding how the biological and molecular function of CIITA
is regulated.
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